Bicarbonate secretion occurs in almost all segments of the gastrointestinal tract. This study examined HCO 3 − secretion in the ileum, since it is less understood than HCO 3 − secretion in other intestinal segments. Mouse ileal mucosa was mounted in vitro in Ussing chambers, and the mucosal alkalinization rate (J OH ) was determined by pH stat titration, while the mucosal side was bathed with a buffer-free solution (100% O 2 ) and the serosal side with a HCO 3 − /CO 2 -buffered solution. The transmural potential difference (PD) was recorded. The mucosal alkalinization rate (J OH ) was higher in the presence of mucosal Cl − than in its absence. Forskolin, an activator of adenylate cyclase, enhanced J OH and PD in both the presence and absence of mucosal Cl − . Mucosal SO 4 2− also caused an increase in J OH , although the magnitude was smaller than that induced by Cl − . Mucosal Cl − -dependent J OH was partially inhibited by acetazolamide, 5-nitro-2-(3-phenylpropylamino)-benzoic acid (NPPB), tenidap and probably also by niflumic acid, but not by glibenclamide, DIDS or bumetanide. The forskolin-induced J OH value and PD were both inhibited by NPPB and probably also by tenidap. It is concluded that HCO 3 − secretion in the ileum follows a mucosal Cl −
−
. Mucosal SO 4 2− also caused an increase in J OH , although the magnitude was smaller than that induced by Cl − . Mucosal Cl − -dependent J OH was partially inhibited by acetazolamide, 5-nitro-2-(3-phenylpropylamino)-benzoic acid (NPPB), tenidap and probably also by niflumic acid, but not by glibenclamide, DIDS or bumetanide. The forskolin-induced J OH value and PD were both inhibited by NPPB and probably also by tenidap. It is concluded that HCO 3 − secretion in the ileum follows a mucosal Cl − -dependent pathway and a cAMP-activated pathway, each being distinct from each other. The Cl − -dependent pathway is probably mediated by the slc26a6 anion exchanger, and possibly also by the slc26a3 anion exchanger. The cAMP-activated HCO 3 − secretion is probably mediated by the cystic fibrosis transmembrane conductance regulator.
Bicarbonate (HCO 3 − ) secretion occurs in almost all segments of the gastrointestinal tract and is essential for the physiology and pathophysiology of the gastrointestinal tract (1, 7, 13, 19, 22, 31) . In most cases, there are at least two mechanisms for bicarbonate secretion, i.e., a mucosal Cl − -dependent and mucosal Cl − -independent type. It is also known that intestinal HCO 3 − secretion is stimulated by cAMP (19, 22, 31) .
The apical membrane process of the Cl − -independent and cAMP-stimulated secretion is assumed to be mediated by the Cl − channel. The cystic fibrosis transmembrane conductance regulator (CFTR) Cl − channel has been assumed to be one of the Cl − channels responsible for HCO 3 − secretion (5, 9, 22, 27, 29) . CFTR is abundantly expressed in the intestinal epithelia, particularly in the crypt region (2, 8) , and is activated by cAMP (24) . On the other hand, the apical membrane process of the Cl − -dependent secretion is assumed to be mediated by the Cl − / HCO 3 − exchanger (5, 13, 14, 19, 22, 25-27, 30, 31 (3, 4, 12, 15, 18, 20, 34) . Both slc26a3 and slc26a6 are expressed throughout the small and large intestines, although slc26a6 expression is higher in the small intestine Measurements of the HCO 3 − secretion and transmural potential difference. The alkaline secretion rate (J OH ) was determined as previously described (6, 13) . Briefly, the mucosal solution was continuously titrated to pH 7.2 with 1 mM H 2 SO 4 under the automatic control of an HSM-10A pH-stat system (Toa Electronics, Tokyo, Japan). The transmural potential difference (PD) was simultaneously recorded by using a voltage-clamp amplifier (Nihon Kohden, Tokyo, Japan) through paired calomel electrodes, each of which was connected to the bathing solutions with a 1 M KCl-2% agar bridge. Neither the diffusion potential across the tissue nor the change in junction potential generated at the tip of the salt bridges was corrected in the present study. We therefore analyzed only the PD change that was induced by forskolin. Tetrodotoxin (0.3 μM) and indomethacin (10 μM) were added to the serosal solution to minimize the effect of neural tone and endogenous prostaglandins, since neurotransmitters and prostaglandins have been shown to modify the intestinal HCO 3 − secretion (22) .
Chemicals. We obtained acetazolamide, glibenclamide, 4,4'-diisothiocyanostilben-2,2'-disulphonic acid (DIDS), niflumic acid, 5-nitro-2-(3-phenylpropylamino)-benzoate (NPPB), bumetanide and indomethacin from Sigma (St. Louis, MO, USA). Tenidap was generously presented by Pfizer (Groton, CT, USA), and tetrodotoxin was purchased from Calbiochem (Darmstadt, Germany).
Statistics.
Each results is the mean ± SE (n = no. of animals). Data were compared by using Student's two-tailed t-test for paired data. Comparisons among three or more groups were made by a one-way analysis of variance (ANOVA) and subsequent Dunnett post test by using StatView software (SAS Institute, Cary, NC, USA). A value of p < 0.05 is considered significant.
RESULTS
We first explored whether a mucosal Cl − -dependent HCO 3 − secretion mechanism was present in the mouse ileum. The mucosal alkalinization rate (J OH ) exhibited a value of 0.71 ± 0.12 μmol × cm −2 × h −1 and slc26a3 expression is higher in the large intestine (11, 18, 26, 32 3 − secretion in the intestine. The purpose of this study is to examine the cellular and membrane mechanisms for HCO 3 − secretion in the mouse ileum, since HCO 3 − secretion in this segment is not as well understood as that in the other intestinal segments. We specifically examined the involvement of CFTR, slc26a3 and slc26a6 in HCO 3 − secretion by determining the effects on HCO 3 − secretion of adding several inhibitors and varying the mucosal main anions by using the pH stat method in vitro in Ussing chambers.
MATERIALS AND METHODS
Tissue preparation. The present experiments were performed under the Guiding Principles for the Care and Use of Animals in the Field of Physiological Sciences recommended by the Physiological Society of Japan. Male mice (ddy; Japan SLC, Shizuoka, Japan) weighing 35-40 g were acclimatized on a standard diet, with food and water being provided ad libitum. The animals were killed by dislocation of the cervical vertebrae, and the ileum was quickly excised. The excised intestinal segment was opened and immersed in an oxygenated HCO 3 − -buffer solution at room temperature, and the tunica muscularis was removed with fine forceps. The tissue sheets were then mounted vertically between Ussing-type chambers that each provided an exposed area of 0.196 cm 2 . The volume of the bathing solution on each side was 10 mL, and the solution temperature was maintained at 37°C in a water-jacketed reservoir. (Fig. 1) . In the next series of experiments, we examined the effects of inhibitors on J OH to explore the underlying cellular and membrane mechanisms for HCO 3 − secretion. We first determined the effect of adding an inhibitor and then of adding forskolin in both the presence and absence of mucosal Cl − , the results being summarized in Fig. 2 (Fig. 1C) . Thus, HCO 3 − secretion that was dependent on mucosal Cl − actually occurred in the ileum.
Solutions
We then explored whether HCO 3 − secretion that was activated by cAMP occurred. Forskolin, an activator of adenylate cyclase to increase cAMP, added to the serosal side (10 μM) increased J OH both in the absence and presence of mucosal Cl − , although the latter increase was significantly smaller than the former (Figs. 1A and 1D ). Forskolin-induced J OH was completely suppressed under the serosal HCO 3 − / Fig. 2 Effect of the inhibitors on J OH and PD. The following inhibitors were added to the mucosal side (in µM): acetazolamide (ACZ, 100), glibenclamide (Gliben, 100), niflumic acid (NA, 30), NPPB (30), tenidap (10) and DIDS (100). Bumetanide was added to the serosal side at a concentration of 50 µM. n = 6, 6, 6, 6, 6, 5 and 5 for acetazolamide, glibenclamide, niflumic acid, NPPB, tenidap, DIDS and bumetanide, respectively. The result shown in Fig. 1 was adopted as the time control (Cont). Each inhibitor was added after baseline J OH had been determined for 30 min. J OH in the presence of an inhibitor was determined for 30 min after a stabilizing period of 10-20 min. Forskolin was then added to obtain forskolininduced J OH . These measurements were taken in the presence and absence of mucosal Cl − using adjacent tissues. (Fig. 3A) . The partial suppression of forskolin-induced J OH by mucosal Cl − shown before was reproduced by all the other anions examined, although only the suppression by I and NO 3 − was statistically significant (Fig. 3B) . The forskolin-induced PD increase in the presence of mucosal Br − , I or NO 3 − was, like Cl − , smaller than that in the presence of gluconate, although the forskolin-induced PD increase in the presence of mucosal SO 4 2− was similar to that in the OH in the presence of each anion. †, significantly different from that in the presence of gluconate. n = 6 for each anion, except for SO 4 2− for which n = 5.
Cl
− . The Cl − -independent HCO 3 − secretion pathway was inhibited by mucosal tenidap, but was insensitive to mucosal niflumic acid, NPPB and DIDS ( Fig. 2A, left panel) , while the forkolin-induced HCO 3 − secretion pathway was inhibited by mucosal NPPB, but was insensitive to mucosal glibenclamide, niflumic acid and DIDS (Fig. 2B, left panel) . Therefore, the apical membrane step on the mucosal Cl − -independent secretion pathway and that on the forskolin-activated secretion pathway are probably distinct from each other. The identity of the molecule responsible for the apical membrane step for mucosal Cl − -independent HCO 3 − secretion is not clear, while forskolin-induced HCO 3 − secretion is probably mediated by apical membrane CFTR. CFTR has been shown to be inhibited by NPPB (17) . In addition, the forskolin-induced PD increase, most of which probably reflected Cl − secretion through the cAMP-activated CFTR Cl − channel, was also inhibited by NPPB, but not by glibenclamide, niflumic acid or DIDS (Fig. 2B, right panel) . It has been reported that cAMP-induced HCO 3 − secretion in the small intestine is inhibited by NPPB and absent in cystic fibrosis model mice (CFTR-null mice) (5, 9, 22, 27, 29) . Glibenclamide is known to inhibit CFTR (17), but had no effect in the present study on either forskolin-induced J OH or PD. It is possible that a higher concentration than that used here (0.1 mM) would be required for inhibiting mouse CFTR in native tissue. CFTR is abundantly expressed in all parts of the small intestine (2, 8) , and has sufficient permeability to HCO 3 − (21, 24). The forskolin-induced HCO 3 − secretion in the presence of mucosal Cl − was significantly less than that observed in its absence ( Figs. 1 and 2 ). Similar observations have also previously been reported for the rabbit duodenum and ileum and for the rat duodenum (19, 27) . The forskolin-induced HCO 3 − secretion was inhibited not only by mucosal Cl − , but also presence of gluconate (Fig. 3C) 4 2− (10, 16, 24, 28) . Since slc26a6, but not slc26a3, are known to transport SO 4 2− in exchange for HCO 3 − , the stimulation by mucosal SO 4 2− of intestinal HCO 3 − secretion is an important clue to the involvement of slc26a6 (4, 12, 15, 26, 34) . Therefore, we repeated the SO 4 2− experiment, although determining J OH in the presence of mucosal gluconate or SO 4 2− with the same tissue in this case. As shown in Fig. 4 , mucosal SO 4 2− slightly but significantly increased J OH , suggesting that slc26a6 was involved in HCO 3 − secretion.
DISCUSSION
The present study on the isolated mouse ileum has shown that HCO 3 − secretion occurred by both the mucosal Cl − -dependent and -independent pathways and that HCO 3 − secretion was enhanced by cAMP. These findings agree with those from previous studies on the ileum from rabbit and mouse, as well as those on the duodenum and jejunum (19, 22, 27, 29) . In addition, we found that the Cl − -dependent pathway strongly depended on carbonic anhydrase, while the Cl − -independent pathway and cAMP-activated secretion were both largely independent of the enzyme. The inhibition of Cl − -dependent HCO 3 − secretion by a carbonic anhydrase inhibitor has been previously reported in the jejunum (22) . HCO 3 − secretion through the Cl − -independent pathway and that through the cAMP-activated pathway exhibited different inhibitor-sensitivity profiles, although both occurred in the absence of mucosal (11, 18, 20, 25, 26, 29, 30, 32, 33) . The present result showing that mucosal SO 4 2− could activate HCO 3 − secretion (Fig. 4) suggests that slc26a6 was at least in part involved, since SO 4 2− can be transported in exchange for HCO 3 − by slc26a6, but not by slc26a3 in a heterologously expressed system (4, 12, 15, 26, 34) . The present results also show that Cl − -dependent HCO 3 − secretion was inhibited by NPPB and tenidap, and also possibly by niflumic acid, but not by DIDS (Fig. 2) . Mouse slc26a6 has been shown to be inhibited by DIDS and niflumic acid, although its sensitivity to tenidap, glibenclamide and NPPB has not been reported (4, 12) . Therefore, although the absence of inhibition by DIDS is unfavorable and requires further study, we feel that slc26a6 was involved at least partly in Cl − -dependent HCO 3 − secretion in the mouse ileum. The inhibitor-sensitivity profile for Cl − -dependent HCO 3 − secretion observed here also generally agrees with that for slc26a3: mouse and human slc26a3 in a heterologous expression system has been inhibited by tenidap, niflumic acid and NPPB, but was relatively resistant to DIDS at the concentrations used here (3, 15, 18) . Therefore, slc26a3 was probably also involved in Cl − -dependent HCO 3 − secretion in the mouse ileum. It cannot be excluded that AE4, another Cl − /HCO 3 − exchanger which has been shown to be present in the apical membrane of the small intestine, could also be responsible for Cl − -dependent HCO 3 − secretion (35) . In conclusion, the present results suggest that there are at least two HCO 3 − secretion mechanisms at work in the mouse ileum: one is Cl − -dependent HCO 3 − secretion mediated by both slc26a3 and slc26a6, and the other is cAMP-stimulated HCO 3 − secretion mediated by CFTR. These findings are generally in agreement with those reported for the duodenum and jejunum. Further studies are clearly
